Shukra Pharmaceuticals Limited (BOM:524632)
India
· Delayed Price · Currency is INR 41.43
-1.75 (-4.05%)
At close: Mar 6, 2026
Shukra Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 121.18 | 99.8 | 39.73 | 2.9 | 5.04 | Upgrade
|
| Cash & Short-Term Investments | 133.58 | 121.18 | 99.8 | 39.73 | 2.9 | 5.04 | Upgrade
|
| Cash Growth | -25.93% | 21.41% | 151.21% | 1271.89% | -42.59% | 299.07% | Upgrade
|
| Accounts Receivable | - | 87.67 | 245.13 | 301.87 | 74.01 | 97.48 | Upgrade
|
| Other Receivables | - | 193.25 | 64.67 | 82.3 | - | - | Upgrade
|
| Receivables | - | 383.22 | 329.59 | 406.95 | 99.5 | 132.1 | Upgrade
|
| Inventory | - | 99.53 | 23.14 | 31.57 | 39.54 | 16.82 | Upgrade
|
| Prepaid Expenses | - | 0.11 | 0.17 | 0.22 | 0.59 | 0.31 | Upgrade
|
| Other Current Assets | - | 50.24 | 109.62 | 52.25 | 16.2 | 6.33 | Upgrade
|
| Total Current Assets | - | 654.27 | 562.33 | 530.72 | 158.72 | 160.6 | Upgrade
|
| Property, Plant & Equipment | - | 213.43 | 216.05 | 218.95 | 192.41 | 193.53 | Upgrade
|
| Long-Term Investments | - | - | - | - | - | 1.95 | Upgrade
|
| Total Assets | - | 867.7 | 778.37 | 749.66 | 351.13 | 356.08 | Upgrade
|
| Accounts Payable | - | 92.16 | 72.21 | 336.22 | 85.9 | 53.29 | Upgrade
|
| Accrued Expenses | - | 15.37 | 10.81 | 9.18 | 10.33 | 7.83 | Upgrade
|
| Current Portion of Long-Term Debt | - | 10.64 | 4.97 | 13.13 | 2.5 | - | Upgrade
|
| Current Unearned Revenue | - | 26.44 | 35.28 | 66.12 | 24.68 | 8.45 | Upgrade
|
| Other Current Liabilities | - | 28.22 | 18.25 | 0.42 | 0.36 | 0.78 | Upgrade
|
| Total Current Liabilities | - | 172.84 | 141.53 | 425.06 | 123.77 | 70.35 | Upgrade
|
| Long-Term Debt | - | 31.13 | 26.57 | 37.68 | 31.27 | 97.71 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 1.27 | 1.15 | 1.08 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 34.11 | 32.73 | 32.87 | 32.6 | 32.03 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | -0 | -0 | - | Upgrade
|
| Total Liabilities | - | 239.34 | 201.98 | 496.7 | 187.63 | 200.09 | Upgrade
|
| Common Stock | - | 437.88 | 109.47 | 39.14 | 15.66 | 15.66 | Upgrade
|
| Additional Paid-In Capital | - | 47.4 | 91.19 | 22.79 | - | - | Upgrade
|
| Retained Earnings | - | 143 | 375.66 | 191.13 | 147.84 | 140.34 | Upgrade
|
| Comprehensive Income & Other | - | 0.08 | 0.08 | -0.09 | - | - | Upgrade
|
| Shareholders' Equity | 658.06 | 628.36 | 576.4 | 252.97 | 163.5 | 155.99 | Upgrade
|
| Total Liabilities & Equity | - | 867.7 | 778.37 | 749.66 | 351.13 | 356.08 | Upgrade
|
| Total Debt | 37.56 | 41.77 | 31.54 | 50.82 | 33.77 | 97.71 | Upgrade
|
| Net Cash (Debt) | 96.02 | 79.41 | 68.27 | -11.09 | -30.87 | -92.66 | Upgrade
|
| Net Cash Growth | -37.28% | 16.33% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.13 | 0.18 | 0.16 | -0.16 | -0.49 | -1.48 | Upgrade
|
| Filing Date Shares Outstanding | 433.29 | 437.88 | 438.39 | 438.39 | 62.63 | 62.63 | Upgrade
|
| Total Common Shares Outstanding | 433.29 | 437.88 | 438.39 | 438.39 | 62.63 | 62.63 | Upgrade
|
| Working Capital | - | 481.44 | 420.79 | 105.66 | 34.95 | 90.25 | Upgrade
|
| Book Value Per Share | 1.38 | 1.44 | 1.31 | 0.58 | 2.61 | 2.49 | Upgrade
|
| Tangible Book Value | 658.06 | 628.36 | 576.4 | 252.97 | 163.5 | 155.99 | Upgrade
|
| Tangible Book Value Per Share | 1.38 | 1.44 | 1.31 | 0.58 | 2.61 | 2.49 | Upgrade
|
| Land | - | 1.72 | 1.72 | 1.72 | 1.7 | 1.72 | Upgrade
|
| Buildings | - | 125.26 | 125.26 | 116.73 | 100.5 | 100.4 | Upgrade
|
| Machinery | - | 307.27 | 282.68 | 277.22 | 248.6 | 233.14 | Upgrade
|
| Construction In Progress | - | 19.45 | 16.62 | 16.62 | 16.62 | 16.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.